Abstract
Executive Summary
Cancer cells frequently and possibly invariably possess apoptotic defects. In
this context, apoptotic pathways provide exciting molecular targets for new
therapeutic agents to specifically promote apoptosis of cancer cells.
There are today more than 240 apoptopic drugs for the treatment of cancer,
from early preclinical to marketed drugs. Apoptosis in Oncology: Drug Pipeline
Update lists all drugs and gives you a progress analysis on each one of them.
Identified drugs are linked to 173 different targets. These targets are
further categorized on the CD-ROM by 51 classifications of molecular function
and with pathway referals to BioCarta, KEGG and NetPath. Read more below on
how the Apoptosis in Oncology: Drug Pipeline Update is organized.
How May Drug Pipeline Update Be of Use?
- Show investors/board/management that you are right on top of drug
development progress in your therapeutic area.
- Find competitors, collaborations partners, M&A candidates etc.
- Jump start competitive drug intelligence operations
- Excellent starting point for world wide benchmarking
- Compare portfolio and therapy focus with your peers
- Speed up pro-active in-/out licensing strategy work
- Fast and easy way of tracking drugs using search engines; just one click
from inside the application and you may search the World Wide Web and PubMed
for any drug.
View Cart
